Advertisement

Topics

3i Company Profile

02:52 EDT 25th September 2017 | BioPortfolio

3i is a world leader in private equity and venture capital.
We are active across all stages of funding. From early-stage venture capital to growth capital and buyouts, we invest €1.5bn a year in some of the most exciting and ambitious companies in the world.

We are dedicated to value creation. Our purpose is to substantially increase the value of our portfolio companies and then to realise this value, both for ourselves and for our partners, through trade sales and stock market listings. Our track record demonstrates that we have consistently achieved this - even in the toughest of bear markets.

3i's international relationship network is unique. Our team of over 300 investment professionals spans three continents, linking us to a wealth of corporate contacts and industry experts. This gives us both a local and global view of industry trends. The breadth of our network ensures that we are able to bring together the best team, with the right experience and relationships for each investment opportunity. It also means we have the scale, the agility and the talent needed to deliver even the most challenging deals.

Location

16 Palace St
London
London
SW1E 5JD
United Kingdom

Contact

Phone: 44 (0)20 7928 3131
Fax: 44 (0)20 7928 0058
Email: london@3i.com


News Articles [1113830 Results]

Managed Care Firms Improperly Cut N.Y. Home Services For Disabled Medicaid Patients: Report

The detailed report by a coalition of more than 100 nonprofit groups finds hundreds of patients were affected.

A Young Woman Dies, A Teen Is Saved After Amoebas Infect The Brain

In Florida, perfect timing and alert medical staff saved a teen from almost certain death. But in North Carolina, one young woman died of an amoeba infection after rafting at a popular tourist site.

Highlights of LIVE Day 1: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017 BOSTON, MA • UNITED STATES

Highlights of LIVE Day 1: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017  BOSTON, MA • UNITED STATES Leaders in Pharmaceutical Business Intelligence (LPBI) Group will cover...

DRÉPANOCYTOSE: La guérison possible par thérapie génique - N Engl J Med

Pour la première un patient atteint de drépanocytose est en rémission complète suite à traitement par thérapie génique. Cet essai clinique de phase I/I...

Gut bacteria could play a role in the development of diseases like Alzheimer's and Parkinson's.

Gut bacteria could play a role in the development of diseases like Alzheimer's and Parkinson's.

Impax Laboratories Receives Form 483 Following FDA Inspection

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility. read more

Beyond the Crisis

First published in 1994, this volume discusses the nature of health care reform and the capacity for medical excellence within the context of such reform.

Interferon-Inducible Protein 10 Is A Potent Inhibitor Of Angiogenesis

Human interferon inducible protein 10 (IP-10) is a member of the chemokine family of molecules. It is a secreted protein with a molecular weight of approximately 8.6 kD. Previous work has demonstrated...

Clinical Trials [126291 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [52534 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

Water Pik, Inc.

Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the Waterpik® brand name. The Company has developed and introd...

More Information about "3i" on BioPortfolio

We have published hundreds of 3i news stories on BioPortfolio along with dozens of 3i Clinical Trials and PubMed Articles about 3i for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 3i Companies in our database. You can also find out about relevant 3i Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record